Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IBRX
IBRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IBRX News
ImmunityBio Director Cheryl Cohen Sells 131,210 Shares
1d ago
Yahoo Finance
Sellas Life Sciences Stock Gains Retail Trader Favor Amid Bullish Sentiment
1d ago
stocktwits
ImmunityBio Officer Plans to Sell 131,210 Shares
2d ago
stocktwits
ImmunityBio Shares Rise as Market Eyes July Catalysts
Jun 30 2026
stocktwits
SLS and IBRX Seize Opportunities in Biotech Sector
Jun 29 2026
stocktwits
IBRX Poised for Potential Inclusion in Russell 1000 Index
Jun 26 2026
stocktwits
Market Mood Shifts to Cautious Optimism Amid Record Equity Inflows
Jun 24 2026
stocktwits
IBRX Poised for Russell 1000 Inclusion Amid Retail Trader Speculation
Jun 24 2026
stocktwits
Federal Reserve's Policy Decision Draws Attention
Jun 17 2026
stocktwits
Investment Recommendations for Cava, Immunitybio, and Trulieve
Jun 17 2026
CNBC
GT Biopharma Advances Three Drug Candidates into Clinical Trials
Jun 08 2026
Globenewswire
GT Biopharma Advances Three Cancer Drug Candidates into Clinical Trials
Jun 08 2026
Newsfilter
Challenges and Opportunities in Neuro-Oncology
Jun 03 2026
Newsfilter
ImmunityBio Showcases ANKTIVA® Research at ASCO Meeting
Jun 01 2026
Newsfilter
GT Biopharma: Three Drugs Enter Human Trials
May 29 2026
PRnewswire
GT Biopharma Advances Three Drug Candidates in Clinical Trials
May 29 2026
Newsfilter
Show More News
